Suscribirse

Understanding persistent airway obstruction in type 2 severe asthma using human induced pluripotent stem cells (iPSCs) - 20/03/24

Doi : 10.1016/j.rmr.2024.01.012 
E. Ahmed 1, , 2 , F. Foisset 3, C. Bourdais 3, A. Nasri 3, A. Petit 1, 4, 5, S. Assou 3, D. Gras 6, P. Chanez 6, 7, I. Vachier 1, 4, 5, H. Hammad 1, J. Vos (De) 3, 8, B. Lambrecht 1, 9, A. Bourdin 1, 4
1 Department of respiratory diseases, CHU de Montpellier, Arnaud-de-Villeneuve Hospital, Inserm, 34000 Montpellier, France 
2 Laboratory of immunoregulation and mucosal immunology, VIB-UGent center for inflammation research, Ghent, Belgium 
3 IRMB, university of Montpellier, Inserm, CHU de Montpellier, 34295 Montpellier, France 
4 PhyMedExp, CNRS, Inserm, CHU de Montpellier, university of Montpellier, Montpellier, France 
5 Medicine biology Mediterranean, department of respiratory diseases and addictology, Arnaud-de-Villeneuve hospital, CHRU de Montpellier, Montpellier, France 
6 C2VN Inserm INRAE, UMR 1263, Aix-Marseille université, Marseille, France 
7 Clinique des bronches, allergies, sommeil, AP–HM, Marseille, France 
8 Department of cell and tissue engineering, university of Montpellier, CHU de Montpellier, 34090 Montpellier, France 
9 Department of internal medicine and pediatrics, Ghent university, Ghent, Belgium 

Corresponding author.

Resumen

Introduction

Despite the new biologics to treat inflammation in severe asthma, targeting persistent obstruction of the airways remains challenging. Galectin-10 eosinophil derived crystals, also known as Charcot-Leyden crystals (CLCs) have been described to be present in the mucus plugs in the airways of patients with severe asthma. However, a direct role for CLCs in mucus production has not been established. We hypothesize that plugged airways constitute a unique niche where type 2 immune cells communicate with structural cells to perpetuate disease. We aimed to set up a new model using induced pluripotent stem cells (iPSCs).

Methods

Three human iPSCs lines from type 2 severe asthma patients have been derived (MOSAIC study, University Hospital of Montpellier, NCT05616338) and differentiated into airway epithelium in air–liquid interface (i-ALI). The healthy iPSC line UHOMi002-A was used as a control. At day 21 of ALI culture, iPSC derived-airway epithelia were stimulated at the apical side with either IL-13 every two days (10ng/mL) during one week, acute stimulation (24h) with recombinant Gal10 crystals (100ng/mL), both IL-13 and Gal10 crystals or PBS (vehicle). We aimed to evaluate the effect on i-ALI differentiation at day 30.

Results

We successfully differentiated the iPSC lines generated from the T2 severe asthma patients, and achieving a high purity rate at each developmental stages. The mean cell purity at the definitive endoderm for each cell line was>80% assessed by flow cytometry quantification of C-X-C Motif Chemokine Receptor 4 (CXCR4)/c-KIT double positive cells and immunolabelling of Forkhead Box A2 (FOXA2)+/SRY-box transcription factor 17 (SOX17)+. Purity for ventral anterior foregut endoderm (vAFE) stage was evaluated at 70%, through Transcription Factor NK2 Homeobox 1 (NKX2.1) expression, Carboxy Peptidase M (CPM) by flow cytometry. vAFE cells from the hiPSC lines differentiated into bronchial epithelium in air–liquid interface conditions. Chronic IL-13 challenging and CLC were both able to induce an increasing of MUC5AC+ cells and also an increase of neuroendocrine cells in asthmatic iPSC lines.

Conclusion

iALI bronchial epithelium can recapitulate T2 severe asthma features in vitro, and highlighted a possible direct effect of the CLC on the airway epithelium.

El texto completo de este artículo está disponible en PDF.

Esquema


© 2024  Publicado por Elsevier Masson SAS.
Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 41 - N° 3

P. 186-187 - mars 2024 Regresar al número
Artículo precedente Artículo precedente
  • Étude des associations entre dérégulations associées aux cils dans l’épithélium des voies aériennes et phénotypes asthmatiques
  • M.A. Devilliers, A. Brisebarre, L.M.G. Petit, M. Polette, G. Deslée, R. Djukanovic, V. Dormoy, J.M. Perotin
| Artículo siguiente Artículo siguiente
  • Développement d’un modèle d’épithélium bronchique innervé par des neurones sensoriels obtenus à partir de cellules souches pluripotentes induites
  • F. Foisset, C. Lehalle, A. Nasri, C. Bourdais, L. Morichon, M. Nadaud, I. Vachier, S. Assou, A. Bourdin, J. De Vos, N. Frossard

¿Ya suscrito a @@106933@@ revista ?